Penn Vet Diabetes Program
The goals of the Penn Vet Diabetes Program are to provide exceptional treatment to diabetic dogs and cats, improve the quality of life of diabetic pets (and their owners), increase longevity of diabetic dogs and cats, decrease risks of diabetic complications and improve understanding of genetics and other disease risk factors.
The Diabetes Program advances the care of diabetic dogs and cats through clinical trials designed to improve the care of our pets. Almost any diabetic dog can be enrolled in an on-going clinical trial. Some on-going trials for diabetic dogs are listed below:
1. Use of glargine insulin for treatment of canine diabetes mellitus,
2. Basal bolus therapy with lispro and NPH insulin,
3. Treatment with diabetic ketoacidosis with lispro insulin,
4. Treatment with diabetic ketoacidosis with aspart insulin,
5. Association between oral disease and regulation of diabetes mellitus,
6. Inflammatory mediators with diabetic ketoacidosis.
For more information, contact Dr. Rebecka Hess, program director, at 215.898.9427 or rhess@vet.upenn.edu.
|
| Some diabetic pets are obese. Treating diabetes mellitus involves weight reduction. Diets of diabetic pets should be modified regardless of body condition. |
|
| Most cats require twice daily insulin injections to treat their diabetes. |
| Diabetic cataracts, common in dogs, can be treated surgically, but optimal diabetic regulation should be achieved before surgery. |
|
| Some dog breeds, such as Samoyeds (top) and Australian terriers are more likely to develop diabetes than other breeds of dogs. |
|